IL6 rs1800797: Understanding This Promoter Variant
The rs1800797 variant is a single-nucleotide polymorphism located in the promoter region of the IL6 gene. It is frequently studied for its potential role in modulating systemic inflammation and influencing levels of C-reactive protein (CRP).
What each genotype means
Typical IL6 promoter activity
This genotype represents the common sequence at the rs1800797 site in the IL6 gene promoter. Research into this variant often examines its role in systemic inflammation and potential associations with conditions like asthma, though findings can vary significantly across different populations and study designs.
This is a common genotype globally, though exact frequencies vary by ancestral background.
Intermediate IL6 promoter variant
Carrying one copy of the A allele at this position may influence the regulation of Interleukin-6, a key inflammatory cytokine. Studies have investigated whether this variant contributes to differences in baseline inflammation markers like C-reactive protein, but the clinical significance remains a subject of ongoing research.
This heterozygous genotype is frequently observed in many populations, reflecting the common nature of the A allele.
Alternative IL6 promoter variant
Individuals with this genotype carry two copies of the A allele, which has been studied for its potential influence on IL6 expression and inflammatory responses. While some research links this variant to specific health traits or inflammatory conditions, these associations are complex and not diagnostic of any specific health outcome.
This genotype is present in a significant portion of the population, consistent with the reported global minor allele frequency of approximately 35%.
What is rs1800797?
The variant rs1800797 is a single-nucleotide polymorphism (SNP) situated within the promoter region of the IL6 gene on chromosome 7. In genetic research, promoter variants are of particular interest because they reside in the regulatory sequences that control how much of a protein is produced. By altering these regulatory regions, a SNP like rs1800797 may influence the transcriptional activity of the gene, potentially leading to differences in the amount of Interleukin-6 protein synthesized by the body. This specific variant is often analyzed alongside other nearby promoter SNPs, such as rs1800796, to understand the complex genetic architecture of the IL6 gene. Because it is located in a non-coding regulatory area, it does not change the structure of the IL-6 protein itself, but rather the timing or quantity of its expression.
The Role of the IL6 Gene
The IL6 gene encodes Interleukin-6, a multifunctional cytokine that plays a central role in the body's immune response. IL-6 acts as both a pro-inflammatory cytokine and an anti-inflammatory myokine, meaning it is involved in a wide array of physiological processes, including the acute-phase response to infection or tissue injury. When the body detects a threat, IL-6 is released to stimulate the production of acute-phase proteins, such as C-reactive protein (CRP), in the liver. Because of its involvement in these pathways, IL-6 is a key focus for researchers studying chronic low-grade inflammation. Understanding how genetic variations in the IL6 promoter might shift the baseline levels of this cytokine is a significant area of study, as it may provide insights into how different individuals manage inflammatory signals.
Research and Evidence
Research into rs1800797 has yielded mixed results, reflecting the complexity of inflammatory genetics. Some studies have investigated its association with systemic inflammation markers like CRP, while others have explored its potential link to conditions such as asthma or susceptibility to certain cancers. However, the evidence strength for these associations is generally considered moderate, and findings are often inconsistent across different populations. For example, while some studies have identified correlations between specific IL6 promoter haplotypes and inflammatory markers, others have found no significant association with disease susceptibility or protein levels. This variability suggests that the impact of rs1800797 may be highly dependent on environmental factors, individual ancestry, or the presence of other genetic modifiers, making it difficult to draw broad clinical conclusions from this single variant alone.
Interpreting Your Information
It is important to recognize that genetic variants like rs1800797 represent only a small piece of a much larger biological puzzle. While scientific literature explores the statistical associations between this SNP and various inflammatory traits, these findings are typically observed at the population level and do not necessarily predict an individual's health outcomes. You cannot use this information to diagnose a condition or determine your personal risk for inflammatory diseases. If you have questions about your health, inflammatory markers, or how your genetic profile might relate to your medical history, you should discuss these topics with a qualified healthcare provider. They can help interpret your results in the context of your overall health, lifestyle, and clinical data, ensuring that any decisions regarding your care are based on comprehensive medical evidence.
How common is this variant?
The rs1800797 variant is common, with a global minor allele frequency (MAF) of approximately 35%. Frequencies can vary significantly depending on ancestral background.
Frequently asked questions
Is rs1800797 a diagnostic test for inflammation?
No, rs1800797 is not a diagnostic test. It is a genetic variant studied for its statistical association with inflammatory markers, but it cannot determine your current health status or diagnose any medical condition.
Does this variant mean I have high inflammation?
Not necessarily. While some research explores links between this variant and inflammatory markers like CRP, many factors including diet, lifestyle, and other genes influence inflammation levels. A genetic variant alone does not dictate your physiological state.
Should I change my diet based on this SNP?
There is no clinical evidence to support changing your diet based on this specific SNP. Always consult with a registered dietitian or your doctor before making significant changes to your nutrition or health regimen.
Where can I find more information on IL6 variants?
You can explore resources like the GWAS Catalog, PubMed, or MedlinePlus Genetics for peer-reviewed research on IL6. These databases provide access to the latest scientific studies regarding genetic associations.
Sources & further reading
Educational information only, last refreshed 10/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800797?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in IL6
Promoter region polymorphism (-572G>C) in interleukin-6 affecting baseline systemic inflammatory tone and cardiovascular disease risk.
Promoter variant (-572 C/G) in interleukin-6 affecting baseline systemic inflammation and cardiovascular risk biomarkers.
This variant is associated with variations in C-reactive protein levels, a key marker of systemic inflammation.
This variant shows a borderline association with late-life survival in European cohorts.